Bird flu death toll rises in China; WHO: Lethal coronavirus spreads human to human;

@FierceBiotech:  FDA accepts $BIIB's BLA for 1st long-lasting factor VIII therapy for hemophilia A. Release | Follow @FierceBiotech

@JohnCFierce: J&J gets a priority review for hep C drug simeprevir (with Medivir). More | Follow @JohnCFierce

@RyanMFierce: Mobile service PharmaSecure finds demand in losing fight against fake drugs. Story | Follow @RyanMFierce

> China has reported three more deaths from a new strain of bird flu, bringing the total number confirmed dead to 35. Report

> California lawmakers are about to debate a new measure that requires pharmacists to notify physicians in case they ever substitute a biosimilar for a branded biologic. Supporters like Amgen ($AMGN) say it's a consumer safety measure, while critics call it a market protection bill that creates roadblocks for knockoffs. Report

Medical Device News

@FierceMedDev: Boston Scientific's Watchman AF device generates more stunning data. Story | Follow @FierceMedDev

@MarkHFierce: Swiss stent maker Biosensors Int'l will pay $51M for a U.S. imaging company - diversification program now under way. More | Follow @MarkHFierce

 @DamianFierce: Glaxo is reaching into Hong Kong with a new DKSH partnership, targeting antibiotics. Article | Follow @DamianFierce

> Israel's budding medical device industry begins to flower. Item

> Sorin wins FDA nod for cardiac monitor. News

> Michigan State develops blood Dx for childhood malaria complication. DxExtra

Pharma News

@FiercePharma: FDA nixes Endo petition to protect Opana ER from generics. Article | Follow @FiercePharma

> Actavis, Warner Chilcott in buyout talks worth $5B-plus. Article

> GlaxoSmithKline's Breo nod augurs new respiratory franchise, analysts say. More

CRO News

> Argentine CRO Stat Research taps Datatrak. News

> Harlan Labs doubles in specialty research with U.S. expansion. Story

> PRA boosts informatics with Welsh expansion. More

> Quintiles hauls in $947M IPO after upping offering. Report

> AMRI piles on profits with strong Q2. Article

Biotech IT News

> Pfizer tests online Viagra sales to beat the cheats. News

> IT outfit Instem acquires Logos to penetrate early clinical trials market. More

> GlaxoSmithKline exec details expectations for online clinical trial research. Article

> Hong Kong billionaire backs Big Data effort in biomedicine at Oxford University. Story

> Pfizer opts to keep running Accelrys software in its labs. Article

And Finally... An official at the World Health Organization has raised fears about a new SARS-like coronavirus, which has killed at least 18 people in the Middle East and Europe. WHO's assistant director-general, Keiji Fukuda, tells reporters that it seems apparent the virus can spread from human to human, but only after prolonged contact. Story

Suggested Articles

The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.

Novartis is picking up Vedere Bio and its preclinical gene therapies for $150 million upfront, with the promise of another $130 million.

When thinking about clinical research patient recruitment, a crucial step is building effective patient recruitment advertising campaigns.